SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-020568
Filing Date
2020-07-28
Accepted
2020-07-28 18:13:16
Documents
1
Period of Report
2020-07-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5811
  Complete submission text file 0000899243-20-020568.txt   7292
Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Issuer) CIK: 0001693011 (see all company filings)

IRS No.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INOZYME PHARMA, INC. 321 SUMMER STREET, SUITE 400 BOSTON MA 02210
Business Address
Schlessinger Joseph (Reporting) CIK: 0001818033 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39397 | Film No.: 201055061